Picture of Danaher logo

DHR Danaher Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-4.35%
3m+6.11%
6m-1.93%
1yr-3.96%
Volume Change (%)
10d/3m-49.24%
Price vs... (%)
52w High-4.04%
50d MA-0.04%
200d MA+6.28%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)32.09
PEG Ratio (f)2.25
EPS Growth (f)16.64%
Dividend Yield (f)0.43%
Valuation (ttm)IndustryMarket
Price to Book Value3.91
Price to Tang. Bookn/a
Price to Free Cashflow38.27
Price to Sales8.62
EV to EBITDA28.64

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.11%
Return on Equity8.32%
Operating Margin22.58%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m17,91122,28424,80226,64323,89023,776.8725,618.216.98%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-6.12+36.56+71.25+12.76-29.54+28.66+14.06n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Danaher EPS forecast chart

Profile Summary

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Directors

Last Annual
December 31st, 2023
Last Interim
June 28th, 2024
Incorporated
October 3rd, 1986
Public Since
December 10th, 1969
No. of Shareholders
2,191
No. of Employees
61,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
722,213,081

DHR Share Price Performance

Upcoming Events for DHR

Q3 2024 Danaher Corp Earnings Call

Q3 2024 Danaher Corp Earnings Release

Q4 2024 Danaher Corp Earnings Release

Similar to DHR

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

Picture of Avanos Medical logo

Avanos Medical

us flag iconNew York Stock Exchange

FAQ